- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04804501
Effect of Blue Light Glasses on Screen Usage After a Concussion in College Students
March 19, 2021 updated by: Zachary Bevilacqua, Rochester Institute of Technology
Premature cessation of screen usage is a common behavior post-concussion, given the taxing nature of a screen-time task.
In the academic setting, screen-time is a near unavoidable component, however, complete avoidance of class and screen use may in fact provoke psychological symptoms of anxiety and depression in students, for fear of falling behind in their studies.
Thus, compensatory measures should be investigated to assist students as they attempt to maintain academic involvement throughout their concussion recovery.
Blue light blocking glasses have been shown to significantly increase screen-time usage in individuals with post-concussion syndrome, yet these results are only representative of a small portion of the concussion population.
Thus, we propose investigating whether blue light blocking glasses can prolong screen usage prior to symptom exacerbation, specifically in concussed students that are still within the normal recovery timeframe.
This cross-sectional randomized clinical trial will provide further evidence of the utility blue light blocking glasses can offer as a therapeutic tool for students recovering from concussion.
We would like to test volunteers from the Rochester Institute of Technology who have been treated by a medical provider within the university's health center.
Blue light glasses will be worn during a one-time computer reading task while the subject is participating in the study.
The total time for the complete the reading task is dependent upon the participant's symptom fluctuations; however, we suspect completion criteria will be met within 20 minutes from beginning.
The risks in this study are minimal and results may increase our understanding of therapeutic tools for patients with ocular-driven concussion symptoms.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14623
- Recruiting
- Rochester Institute of Technology
-
Contact:
- Zachary Bevilacqua, PhD, ATC
- Phone Number: 585-313-4608
- Email: zwbihst@rit.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 24 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Full-time student at RIT
- Diagnosed mild traumatic brain injury
- Between 18-26 years of age
- Within 3-14 days post-injury
Exclusion Criteria:
- Any head, neck, or face injury in the 1 year prior to the study (e.g., concussion, eye injury) other than the current injury
- History of vestibular or ocular dysfunction\
- Any neurological disorders (e.g., seizure disorders, closed head injuries with loss of consciousness greater than 15 minutes, CNS neoplasm, history of stroke)
- Injury more severe than mild traumatic brain injury (skull fracture, positive CT or MRI)
- Having taken pain medication within 8 hours prior to testing
- Not able to personally consent
- Pregnant
- Deaf or hard of hearing.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Blue Light Glasses (experimental)
These subjects will wear the device (glasses) while performing a reading task.
|
Participants will be randomized into an experimental group (blue light glasses) or a control group (no glasses).
Participants will perform a computer reading task while either wearing, or not wearing the glasses.
Participants will read on a computer until concussion symptoms increase by a score of 3 or more (reading task termination criteria).
One or more points will be assigned for each increase in symptom severity, and one point will be assigned for each new symptom that appears.
|
Other: No Glasses (control)
These subjects will not wear the device (glasses) while performing a reading task.
|
Participants will read on a computer until concussion symptoms increase by a score of 3 or more (reading task termination criteria).
One or more points will be assigned for each increase in symptom severity, and one point will be assigned for each new symptom that appears.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time on Screen
Time Frame: 30 minutes or less
|
The amount of time a participant can spend on time, prior to meeting termination criteria, will be recorded and compared between experimental and control groups.
|
30 minutes or less
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
March 15, 2021
First Submitted That Met QC Criteria
March 15, 2021
First Posted (Actual)
March 18, 2021
Study Record Updates
Last Update Posted (Actual)
March 23, 2021
Last Update Submitted That Met QC Criteria
March 19, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RochesterIT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Concussion
-
Sync-Think, Inc.CompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion; Eye | Concussion, CerebralUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
Boston Children's HospitalUniversity of Colorado, DenverCompletedConcussion, Mild | Concussion, Brain | Concussion, Severe | Exertion; ExcessUnited States
-
Sport Injury Prevention Research CentreUniversity of ManitobaUnknownTraumatic Brain Injury | Rehabilitation | Post-Concussion Syndrome | Aerobic Exercise | Concussion, Brain | Physiological Post-Concussion DisorderCanada
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Intermediate | Near Point ConvergenceUnited States
-
Children's National Research InstituteCompletedPediatric ALL | Concussion, Mild | Concussion, Brain | Concussion, IntermediateUnited States
Clinical Trials on Blue Light Glasses
-
University of Alabama at BirminghamCompletedAttention Deficit Hyperactivity Disorder | Delayed Sleep Phase Type Circadian Rhythm Sleep DisorderUnited States
-
Universiteit LeidenEindhoven University of Technology; Geestelijke Gezondheidszorg Eindhoven (GGzE) and other collaboratorsNot yet recruitingDepression, Unipolar | Depression, BipolarNetherlands
-
Geestelijke Gezondheidszorg Eindhoven (GGzE)RecruitingBipolar Disorder | Prodromal Symptoms | Mood SwingNetherlands
-
University of PittsburghNational Institute of Mental Health (NIMH)RecruitingDepression in Adolescence | Depression in AdultsUnited States
-
Michigan State UniversityNot yet recruiting
-
Shanghai Zhongshan HospitalFudan University; Shanghai Mental Health Center, Jingan District; Shanghai Mental...Unknown
-
University of PittsburghWithdrawn
-
Chang Gung Memorial HospitalRecruitingDelirium | Circadian DysrhythmiaTaiwan
-
Glostrup University Hospital, CopenhagenPhilips Healthcare; Elforsk; Albertslund Kommune; Gate 21; DTU Fotonik; VISO systems; AF Lightning and other collaboratorsCompleted
-
Matthew Neal MDTerminatedPancreatic Neoplasms | Rectal NeoplasmsUnited States